What is CVE-2026-9614?
An Improper Access Control vulnerability in Ivanti Neurons for ITSM (cloud and on-premises) allows a remote authenticated attacker to gain administrative access.
The record classifies CVE-2026-9614 under weakness class CWE-284. Its CVSS v3 base vector states that the flaw is reachable remotely over the network, needs low-privilege credentials, needs no user interaction, and has high impact on confidentiality, integrity, availability. 2 affected-product entries are recorded, across 1 vendor, listed below. The identifier was first published 137 days ago.
Severity and exploitation probability
- CVSS v3.1 base score
- 8.8 — HIGH
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:H - EPSS (FIRST)
- 1.2% probability of exploitation in the next 30 days, higher than 67.5% of all scored CVEs
- CISA KEV
- Not listed in the CISA Known Exploited Vulnerabilities catalog
- Threadlinqs priority
- 7.1/10 — a Threadlinqs composite of the CVSS base score, the EPSS percentile and public exploit availability
- Published
- 2026-06-01, last modified 2026-06-02
Is CVE-2026-9614 being exploited?
It currently carries a trending score of 22 in the Threadlinqs vulnerability feed.
Affected products and versions
- Ivanti: Neurons for ITSM (On-Premises), Neurons for ITSM (Cloud)
How to fix CVE-2026-9614
No vendor patch reference has been recorded for CVE-2026-9614 in the tracked sources. Follow the references below for a fix, and treat the products listed above as exposed until the vendor states otherwise.
Threat activity tracking CVE-2026-9614
1 tracked threat in the Threadlinqs corpus references CVE-2026-9614, either in the campaign’s CVE list or as an indicator on the campaign record.
Sources
Enriched from CVE.org, NVD, FIRST EPSS, GitHub Security Advisories. Last verified by Threadlinqs on . This product uses the NVD API but is not endorsed or certified by the NVD.